Immuneering Corporation Class A Common Stock (IMRX)
Immuneering Corporation Class A Common Stock (IMRX) has reported earnings 20 times since Sep 09, 2021. The stock moves an average of ±5.19% the day after reporting, closing higher 65.0% of the time. Its largest post-earnings gain was +15.04% (Nov 13, 2024) and its largest decline was -10.94% (Aug 06, 2024). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings reactions
How IMRX moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±5.19%
Positive %
65.0%
Negative %
35.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 15, 2026 | ☀ PRE | +0.58% | open_in_new |
| Mar 06, 2026 | ☀ PRE | +6.83% | open_in_new |
| Nov 12, 2025 | ☽ POST | -2.58% | open_in_new |
| Aug 13, 2025 | ☽ POST | -6.35% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±5.19%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260717 | open_in_new SEC.gov |
| 3 | 20260716 | open_in_new SEC.gov |
| 4 | 20260624 | open_in_new SEC.gov |
| 4 | 20260616 | open_in_new SEC.gov |
| 8-K | 20260615 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
Frequently asked about IMRX earnings
When does Immuneering Corporation Class A Common Stock report earnings next? expand_more
Immuneering Corporation Class A Common Stock (IMRX)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does IMRX stock move after earnings? expand_more
Over 20 reports, IMRX has moved an average of ±5.19% the session after earnings, closing higher 65.0% of the time.
What was IMRX's biggest post-earnings move? expand_more
IMRX's largest post-earnings gain on record was +15.04% on Nov 13, 2024, and its largest decline was -10.94% on Aug 06, 2024.
Where can I find Immuneering Corporation Class A Common Stock's SEC filings? expand_more
All of Immuneering Corporation Class A Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07